DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 129 filers reported holding DENALI THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 258.00 and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $32,333,584 | -30.3% | 1,567,309 | -0.4% | 0.03% | -28.3% |
Q2 2023 | $46,420,647 | +29.7% | 1,573,048 | +1.3% | 0.05% | +27.8% |
Q1 2023 | $35,791,995 | -16.1% | 1,553,472 | +1.3% | 0.04% | -20.0% |
Q4 2022 | $42,643,381 | -13.8% | 1,533,383 | -4.8% | 0.04% | -18.2% |
Q3 2022 | $49,455,000 | -14.3% | 1,611,429 | -17.8% | 0.06% | -8.3% |
Q2 2022 | $57,683,000 | -8.5% | 1,960,025 | +0.1% | 0.06% | +11.1% |
Q1 2022 | $63,008,000 | -28.1% | 1,958,574 | -0.3% | 0.05% | +14.9% |
Q4 2021 | $87,579,000 | -12.4% | 1,963,648 | -0.9% | 0.05% | -14.5% |
Q3 2021 | $100,015,000 | -35.2% | 1,982,473 | +0.8% | 0.06% | -32.9% |
Q2 2021 | $154,253,000 | +38.0% | 1,966,508 | +0.4% | 0.08% | +43.9% |
Q1 2021 | $111,802,000 | -4.8% | 1,957,993 | +39.6% | 0.06% | 0.0% |
Q4 2020 | $117,494,000 | +3934.8% | 1,402,750 | +1626.2% | 0.06% | +2750.0% |
Q3 2020 | $2,912,000 | +17.3% | 81,264 | -20.8% | 0.00% | 0.0% |
Q2 2020 | $2,483,000 | +243.4% | 102,647 | +148.5% | 0.00% | +100.0% |
Q1 2020 | $723,000 | -1.2% | 41,307 | -1.7% | 0.00% | 0.0% |
Q4 2019 | $732,000 | -0.3% | 42,004 | -12.3% | 0.00% | 0.0% |
Q3 2019 | $734,000 | -14.1% | 47,898 | +16.3% | 0.00% | 0.0% |
Q2 2019 | $854,000 | -19.7% | 41,187 | -10.0% | 0.00% | 0.0% |
Q1 2019 | $1,063,000 | +16.8% | 45,764 | +3.8% | 0.00% | 0.0% |
Q4 2018 | $910,000 | +61.3% | 44,091 | +70.3% | 0.00% | 0.0% |
Q3 2018 | $564,000 | +211.6% | 25,894 | +117.0% | 0.00% | – |
Q2 2018 | $181,000 | – | 11,934 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Crestline Management, LP | 7,460,732 | $240,012,000 | 28.78% |
Casdin Capital, LLC | 1,500,000 | $48,255,000 | 2.16% |
Flagship Pioneering Inc. | 2,619,968 | $84,284,000 | 1.98% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 38,000 | $8,192,000 | 1.85% |
Yiheng Capital Management, L.P. | 1,014,684 | $32,642,000 | 1.49% |
SECTORAL ASSET MANAGEMENT INC | 207,100 | $6,662,000 | 1.18% |
Artal Group S.A. | 600,000 | $19,302,000 | 0.81% |
GILDER GAGNON HOWE & CO LLC | 2,619,217 | $84,260,000 | 0.78% |
Temasek Holdings (Private) Ltd | 5,369,487 | $172,736,397 | 0.73% |
BRANDYWINE MANAGERS, LLC | 9,601 | $309,000 | 0.53% |